United Therapeutics

$130.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$6.60 (+5.35%) As of 11:09 AM EDT today

Why Robinhood?

You can buy or sell UTHR and other stocks, options, and ETFs commission-free!

About UTHR

United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. Read More The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. The listed name for UTHR is United Therapeutics Corporation Common Stock.

Employees
920
Headquarters
Silver Spring, Maryland
Founded
1996
Market Cap
5.74B
Price-Earnings Ratio
12.69
Dividend Yield
Average Volume
618.16K
High Today
$132.02
Low Today
$121.75
Open Price
$121.75
Volume
486.77K
52 Week High
$132.02
52 Week Low
$75.58

Collections

UTHR News

Benzinga4h

Recap: United Therapeutics Q3 Earnings

Shares of United Therapeutics (NASDAQ:UTHR) remained unaffected after the company reported Q3 results. Quarterly Results Earnings per share increased 1.31% ov

UTHR Earnings

$1.96
$2.60
$3.24
$3.88
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
$2.78 per share
Actual
$3.88 per share

You May Also Like